NCT02914028

Brief Summary

Inguinal hernia repair with mesh has a high incidence of postoperative chronic pain. Transversus abdominis plane block is a current intervention to support postoperative analgesia, however it is recently in research area how to be applied in different surgical areas to be more effective than intravenous opioids. Subcostal transversus abdominis plane block is not advised but has not been studied to be effective for postoperative analgesia in inguinal herniography patients. This study aims to research the effect of subcostal transversus abdominis plane block in subacute postoperative pain after inguinal hernia repair

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable postoperative-pain

Timeline
Completed

Started Apr 2016

Shorter than P25 for not_applicable postoperative-pain

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

August 26, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 26, 2016

Completed
Last Updated

February 27, 2019

Status Verified

February 1, 2019

Enrollment Period

4 months

First QC Date

August 26, 2016

Last Update Submit

February 25, 2019

Conditions

Keywords

TAP blocksubacute paininguinal herniography

Outcome Measures

Primary Outcomes (1)

  • verbal numeric scale

    patients were questioned for pain graduation to give a point from 0 to 10 according to the intensity of the pain. 0 equals to no pain, 10 equals to the strongest pain

    1 month after the operation

Secondary Outcomes (1)

  • verbal numeric scale

    15 minutes, 1-6-12-24 hours and 15 days after operation

Study Arms (2)

Tramadol and paracetamol

ACTIVE COMPARATOR

subjects were administered intravenous analgesia (control group) Tramadol 100 mg and paracetamol 1000 mg at the end of the surgery

Drug: Tramadol and paracetamol

transversus abdominis plane block

ACTIVE COMPARATOR

patients that applied transversus abdominis plane block at the end of the surgery after given intravenous analgesia

Procedure: transversus abdominis plane blockDrug: Tramadol and paracetamol

Interventions

A peripheric block needle is inserted entering the facia between musculus rectus abdominis and musculus transversus abdominis with ultrasonography and local anesthetics are injected in the facia.

Also known as: stimuplex A
transversus abdominis plane block

Tramadol 100 mg and paracetamol 1000 mg are applied to the patients at the end of the surgery

Also known as: contramal, parol infusion solution
Tramadol and paracetamoltransversus abdominis plane block

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I-III
  • who were to undergo elective unilateral inguinal herniography with "mesh" under general anesthesia.

You may not qualify if:

  • patients who have allergy to local anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain, Postoperative

Interventions

UltracetTramadol

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

CyclohexanolsHexanolsFatty AlcoholsAlcoholsOrganic ChemicalsDimethylaminesMethylaminesAminesLipids

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medical doctor

Study Record Dates

First Submitted

August 26, 2016

First Posted

September 26, 2016

Study Start

April 1, 2016

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

February 27, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share